19h
Hosted on MSNNICE green lights two blood cancer therapies for NHS useBMS’ Breyanzi and Amgen’s Blincyto will now be available to patients in England with certain types of blood cancer.
In a sense, every investor is a growth investor. Even those who are primarily seeking income enjoy when the stocks they buy ...
Using an arcane law, officials have effectively delayed funding from the National Institutes of Health, leaving medical ...
Netradyne, an industry-leading SaaS provider of artificial intelligence (AI) and edge computing, today announced the editors of Heavy Duty Trucking named Netradyne's cutting-edge Driver Drowsiness ...
Imagine a cancer treatment that precisely targets malignant cells, leaving healthy ones untouched. Consider, also, a cancer treatment that corrects abnormal protein synthesis to produce healthy ...
More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results